access to treatment

Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak

Press Release

FOSTER CITY, Calif., March 25, 2020 /3BL Media/ – For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and support needed.

Bill & Melinda Gates Foundation, Wellcome and Mastercard Launch Initiative to Speed Development and Access to Therapies for COVID-19

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic
Press Release

SEATTLE, March 10, 2020 /3BL Media/ – The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings.

Driving Transformational Innovation in HIV Research

By Diana Brainard, MD, Senior Vice President for HIV and Emerging Viruses at Gilead
Blog

When I was a medical student in the mid-1990s, the scope and impact of the HIV/AIDS epidemic was devastating and there was little hope for long-term survival. During rotations at Charity Hospital in New Orleans, I observed people living with HIV demonstrate courage, as well as numerous healthcare professionals providing compassionate care.

Nourishing Future Generations with Vitamin Angels

Multimedia with summary

Good nutrition is essential for a healthy start in life and the foundation for optimal growth and development. For pregnant women and infants, having access to the right micronutrients is especially important as a child who is well nourished in the crucial first 1,000 days of their life is ten times more likely to overcome life-threatening childhood diseases and will complete 4.6 more grades at school.

Astellas Global Health Foundation Launches

Foundation to Support Improving Access to Health for Underserved Populations
Press Release

Responding Disruptively to a Most Profound Disruption: Working to Help Childhood Cancer Survivors

By Murdo Gordon, Chief Commercial Officer, Bristol-Myers Squibb
Blog

To say that childhood cancer is profoundly disruptive doesn’t begin to scratch the surface of the impact the disease has on young patients and their families. The diagnosis changes everything in an instant. Then there is treatment, which often separates a young girl or boy from family and friends; from school; and from the life one knew or the life not yet really begun.

Subscribe to access to treatment